Skip to main navigation

homepage

Return to DayOneBio.com
OVERVIEW
NEWS & EVENTS
STOCK INFORMATION
- Stock quote & chart
- Analyst coverage
FINANCIAL INFORMATION
CORPORATE GOVERNANCE
INVESTOR RESOURCES

Events

NEWS & EVENTS

Press releases
Events
Corporate presentation

Upcoming Events

43rd Annual J.P. Morgan Healthcare Conference

Jan 13, 2025 6:45 PM EST

Add to Google Calendar

Past Events

Piper Sandler 36th Annual Healthcare Conference

Dec 03, 2024 3:00 PM EST

Day One Biopharmaceuticals Q3 2024 Earnings Conference Call

Oct 30, 2024 4:30 PM EDT

Day One Biopharmaceuticals Q3 2024 Earnings Conference Call Presentation

Day One Biopharmaceuticals Q2 2024 Earnings Conference Call

Jul 30, 2024 8:00 AM EDT

Day One Biopharmaceuticals Q2 2024 Earnings Conference Call Presentation

OJEMDA™ FDA Approval Call

Apr 24, 2024 8:30 AM EDT

OJEMDA FDA Approval Call Presentation

Day One Conference Call

Jun 04, 2023 6:00 PM CDT

ASCO 2023 Conference Call Presentation

Initial Data from Pivotal FIREFLY-1 Trial of Tovorafenib (DAY101) in Relapsed Pediatric Low-Grade Glioma

Jun 13, 2022 8:00 AM EDT

Initial Data from Pivotal FIREFLY-1 Trial of Tovorafenib (DAY101) in Relapsed Pediatric Low-Grade Glioma

Investor Contact

Investor Relations

drafts investors@dayonebio.com

Media Contact

Laura Cooper

drafts Media@dayonebio.com

Subscribe to our Email Alerts

Email Address

© Day One Biopharmaceuticals, Inc.

|

Privacy Policy
Terms of Use

Search Investors

Search this site